HIGHLIGHTS
- who: Christoph Rogmans et al. from the Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany have published the article: Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages, in the Journal: Cancers 2022, 5867 of /2022/
- what: The aim of this study is to investigate whether the ADAM17 substrates Nectin-4 Heparin-binding EGF-like growth factor and_(AREG) could function as potential tumor markers for The study proposes Nectin-4 and as promising blood-based biomarkers for the detection . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.